Evaluating First-line Chemotherapy Regimens and Platinum Choices in HER2-Negative Metastatic Gastric Cancer: A Retrospective Analysis

Objective: The survival advantage of triplet versus doublet chemotherapy regimens and cisplatin versus oxaliplatin-based therapies for first-line treatment in human epidermal growth factor receptor 2 (HER2)-negative metastatic gastric cancer remains unclear. This study aimed to evaluate and compare...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Caner ACAR, Haydar Çağatay YÜKSEL, Salih TÜNBEKİCİ, Gökhan ŞAHİN, Fatma Pınar AÇAR, Burçak KARACA
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Turkish Society of Oncology 2025-08-01
Edice:	Journal of Oncological Sciences
Témata:	adenocarcinoma cancer diagnosis and treatments medical oncology
On-line přístup:	https://journalofoncology.org/articles/evaluating-first-line-chemotherapy-regimens-and-platinum-choices-in-her2-negative-metastatic-gastric-cancer-a-retrospective-analysis/doi/jos.galenos.2025.2025-6-2
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!